Compare · ACCD vs OTRAU
ACCD vs OTRAU
Side-by-side comparison of Accolade Inc. (ACCD) and OTR Acquisition Corp. (OTRAU): market cap, price performance, sector, and recent activity on the wire.
Summary
- ACCD operates in Consumer Discretionary, while OTRAU operates in Finance - the two are in different parts of the market.
- ACCD carries a market cap of $1.18B.
- ACCD has more recent analyst coverage (25 ratings vs 0 for OTRAU).
- Company
- Accolade Inc.
- OTR Acquisition Corp.
- Price
- $7.03+0.00%
- $10.40+1.27%
- Market cap
- $1.18B
- -
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Business Services
- Business Services
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2020
- 2020
- News (4w)
- 0
- 0
- Recent ratings
- 25
- 0
Accolade Inc.
Accolade, Inc. develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and clinicians, including nurses, physician medical directors, and behavioral health specialists. It also provides second opinion consultation and health care decision support services. The company serves employers who provide their employees and their employees' families a single place to turn for their health, healthcare, and benefits needs. Accolade, Inc. was founded in 2007 and is headquartered in Plymouth Meeting, Pennsylvania.
OTR Acquisition Corp.
OTR Acquisition Corp. does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar business combination with one or more businesses or entities. The company was incorporated in 2020 and is based in Miami, Florida.
Latest ACCD
- Defining Wellness Centers Names Bill Morrison Chief Financial Officer
- SEC Form 15-12G filed by Accolade Inc.
- Amendment: SEC Form SCHEDULE 13D/A filed by Accolade Inc.
- SEC Form 25-NSE filed by Accolade Inc.
- SEC Form S-8 POS filed by Accolade Inc.
- SEC Form S-8 POS filed by Accolade Inc.
- SEC Form S-8 POS filed by Accolade Inc.
- SEC Form S-8 POS filed by Accolade Inc.
- SEC Form S-8 POS filed by Accolade Inc.
- Chief Executive Officer Singh Rajeev returned $10,429,525 worth of shares to the company (1,483,574 units at $7.03), closing all direct ownership in the company (SEC Form 4)
Latest OTRAU
- Comera Life Sciences Debuts as Publicly Traded Company Focused on Transforming Biologics
- 6 Stocks Halted In Wednesday's Session: Here's Why
- Comera Life Sciences and OTR Acquisition Corp. Announce Effectiveness of Registration Statement for Proposed Business Combination
- OTR Acquisition Corp. Reports Filed Confidential Submission Of S-4 Registration Statement Related To SPAC Deal With Comera Life Sciences
- OTR Acquisition Corp. Announces Confidential Submission of S-4 Registration Statement Related to Proposed Business Combination
- Comera Life Sciences To Become Publicly Traded via Business Combination With OTR Acquisition Corp.; Combined Co. To Have Implied Equity Vale $258.4M
- Comera Life Sciences to Become Publicly Traded via Business Combination with OTR Acquisition Corp.
- SEC Form 10-Q filed